Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
HUBER high precision thermoregulation in laboratories: ECO² - Economical and Ecological!
Friday, May 17, 2013
HUBER Petite Fleur®, Ministat® and Minichiller® are environmentally friendly and cost-effective thermoregulation machines charged with natural refrigerants, perfectly suited for laboratories: Eco friendly, small dimensions and low investment costs.

Molecular Devices to Exhibit at French Neuroscience 2013
Monday, May 13, 2013
Molecular Devices will be showcasing their Axon™ Digidata® 1550 Low-Noise Data Acquisition System.

Molecular Devices Launches Axon Digidata 1550 Low-Noise Data Acquisition System
Thursday, May 09, 2013
High performance, high throughput system designed to support the most challenging electrophysiology research.

ELRIG Announces Drug Discovery 2013 Preliminary Programme and Call for Posters
Thursday, May 02, 2013
The 7th Annual Drug Discovery Conference is anticipated to attract over 1000 delegates, engaging scientists involved in early stage drug discovery.

GSK Validates High Throughput Format of Gentronix BlueScreen® Assay
Thursday, April 25, 2013
BlueScreen-384 provides robust, reproducible, and consistent results.

Randox Launches ELISA
Tuesday, April 23, 2013
Detection of new generation Synthetic Cannabinoids (Spice) drugs UR-144 and XLR-11.

Molecular Devices Introduces FLIPR Calcium 6 Assay Kits
Tuesday, April 23, 2013
Latest addition to the FLIPR Calcium range featuring exclusive fluorophore for assaying the most challenging, low-responding targets.

High Pressure IC Speeds Separations of Counter Ions in a Drug Tablet
Friday, April 19, 2013
New technical note on rapid separation and quantification of counter ion using Dionex ICS-5000+ HPIC system.

HµrelStaticDog™, Hµrel Corporation’s In Vitro Cell Culture of Canine (Dog) Liver Cells, to be Presented at Toxicology Conference
Thursday, April 11, 2013
Data highlight benefits of new tool for predicting drug toxicity in humans before clinical trials begin - important milestone in drug development evolution.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 641
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv